Lee Tom Y 4
4 · PURE BIOSCIENCE, INC. · Filed Mar 22, 2022
Insider Transaction Report
Form 4
Lee Tom Y
Director
Transactions
- Purchase
Common Stock
2022-03-16$0.18/sh+21,227$3,821→ 4,753,593 total - Purchase
Common Stock
2022-03-17$0.18/sh+13,250$2,372→ 4,766,843 total - Purchase
Common Stock
2022-03-21$0.20/sh+185,000$36,630→ 4,951,843 total
Holdings
- 1,000,000(indirect: By Trust)
Common Stock
- 1,000,000(indirect: By Trust)
Common Stock
- 1,000,000(indirect: By Trust)
Common Stock
- 13,401,951(indirect: By Plum Investments, L.P.)
Common Stock
- 717,665(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.194 to $0.1998. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.
- [F3]Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares